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Proteomic identification of protease cleavage site specificity
(PICS) is a recent proteomic approach for the easy mapping
of protease subsite preferences that determines both the
prime- and non-prime side specificity concurrently. Here we
greatly facilitate user access by providing an automated and
simple web-based data-analysis resource termed WebPics
(http://clipserve.clip.ubc.ca/pics/). We demonstrate the utility
of WebPics analysis of PICS data by determining the sub-
strate specificity of factor Xa from P6-P6’, an important
blood coagulation protease that proteolytically generates
thrombin from prothrombin. PICS confirms existing data on
non-prime site specificity and refines our knowledge of fac-
tor Xa prime-site selectivity.
Keywords: peptide library; prime-site specificity; protease
specificity.
The intrinsic and extrinsic pathways of blood coagulation
merge at the factor Xa-mediated activation of prothrombin.
In vivo, prothrombin activation involves formation of a
membrane surface complex between factor X and factor Va
(Krishnaswamy et al., 1988). Hence, factor Xa, a very selec-
tive secreted S1 family serine protease, executes an essential
role in hemostasis. As such, factor Xa is directly targeted by
anticoagulant drugs such as rivaroxaban, apixaban or edoxa-
ban (Harbrecht, 2011). In addition to prothrombin, factor Xa
proteolytically activates factors V, VII, and VIII (Bajaj et al.,
1981; Foster et al., 1983; Parker et al., 1997) as well as
protease-activated receptor 2 (Camerer et al., 2000), but little
else.
Factor Xa is highly specific and indeed is frequently used
for removal of tags from recombinant fusion proteins (Nagai
et al., 1985). Across species, the physiological cleavage sites
of factor Xa in prothrombin, factor VII and factor V share a
P1 arginine and a P2 glycine residue (Brandstetter et al.,
1996). This specificity profile has been supported by bio-
chemical and genetic profiling strategies. Thus, at S1 factor
Xa is considered to be specific for arginine (Matthews and
Wells, 1993; Scholle et al., 2006) although one study
employing synthetic peptide libraries also revealed specific-
ity profiles having a P1 lysine (Gosalia et al., 2005). S2 also
has a strong contribution to factor Xa specificity. In addition
to the canonical specificity for glycine (Cho et al., 1984;
Kawabata et al., 1988; Matthews and Wells, 1993; Scholle
et al., 2006), there is increasing evidence for a partial pref-
erence for aromatic and aliphatic residues in S2, in particular
phenylalanine (Harris et al., 2000; Bianchini et al., 2002;
Furlong et al., 2002; Gosalia et al., 2005; Hsu et al., 2008).
Further removed from the scissile bond and based on sev-
eral physiological cleavage sites, factor Xa exhibits a S3
preference for acidic residues. As well, this has been corrob-
orated with synthetic peptide libraries (Cho et al., 1984;
Kawabata et al., 1988). However, other studies indicated that
negatively charged residues are disfavored in S3 (Bianchini
et al., 2002) with P3 arginine being partially preferred in two
substrate phage display screens (Scholle et al., 2006; Hsu et
al., 2008) as well as in a synthetic peptide library screen
(Furlong et al., 2002). The latter study also indicated a sec-
ond, partial S3 preference for aromatic and aliphatic residues
including phenylalanine, tyrosine, and leucine. At S4, a com-
binatorial peptide library determined a minor specificity for
isoleucine, arginine or proline (Furlong et al., 2002); how-
ever, this was not confirmed by a second study that did not
reveal P4 specificity determinants (Harris et al., 2000).
Profiling of prime-site specificity yields contrasting
results. While one study suggests an equal contribution of
S2’ and S1’ to overall factor Xa specificity (Bianchini et al.,
2002), the results of another study point towards a limited
influence of prime-site selectivity (Ludeman et al., 2003).
S1’ is described as preferring small or hydrophilic residues
(serine, alanine, threonine) (Bianchini et al., 2002). However,
a second specificity screen suggests a mixed preference for
alanine alongside aromatic or aliphatic residues (Ludeman
et al., 2003). In S2’, both studies determine partial selectivity
for glycine and alanine together with a minor preference for
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aromatic or aliphatic residues (Bianchini et al., 2002; Lude-
man et al., 2003). For S3’, no preference has emerged
(Bianchini et al., 2002; Ludeman et al., 2003). It is not clear
whether it is the different techniques or inter-laboratory var-
iability that has led to these differences in the profiles for
prime and non-prime site specificity of factor Xa. In view
of the medical importance of factor Xa and it being such an
important drug target, the specificity of this enzyme needs
to be completely understood.
A recent novel proteomic approach for determining both
prime and nonprime side specificity in the same experiment
termed ‘pIroteomic iIdentification of protease cIleavage site
sIpecificity’ (PICS) (Schilling and Overall, 2008) is designed
for rapid protease selectivity determination. PICS focuses on
biologically relevant sequences by employing proteome-
derived peptide libraries that consequently are database
searchable. In contrast to substrate phage display and fluo-
rescence resonance energy transfer based synthetic peptide
libraries, PICS unambiguously locates the scissile peptide
bond. PICS determines individual prime-side cleavage
sequences by liquid chromatography (LC)-tandem mass
spectrometry (MS/MS) with the corresponding non-prime
sequences being derived using bioinformatics. The large
cohort of cleavage sequences identified in each PICS exper-
iment allows for the analysis of potential subsite cooperati-
vity as has been demonstrated for HIV protease 1 (Ridky
et al., 1996; Schilling and Overall, 2008).
PICS libraries are first prepared from cellular proteomes
by digesting first with specific endopeptidases, such as tryp-
sin, chymotrypsin or Glu-C. This protease is then inactivated.
Then, thiol and amine groups (N-terminal a-amines and
lysine ´-amines) are chemically protected. The peptide mix-
ture is then cleaned up and the proteome-derived peptide
library is purified. Aliquots of the library are then used as
substrate for the test protease in the PICS assay. Unlike the
non-cleaved peptides in the library, which have blocked pri-
mary amines, the cleaved prime-side cleavage products dis-
play a reactive N-terminal primary amine on their neo-
N-termini, allowing for specific biotinylation by NHS chem-
istry, affinity isolation, and sequence identification by LC-
MS/MS. The corresponding non-prime sequences are
determined using bioinformatics.
While PICS employs standard reagents without the need
for peptide synthesis, its broad usability was hampered by a
multi-step protocol for data analysis that requires expert
knowledge for command line utilities and spreadsheet appli-
cations. This has now been addressed by a web-based inte-
grated series of data handling scripts behind a convenient
and easy user interface termed WebPICS (Schilling et al.,
2011). The resource is freely accessible as a web-based
application (http://clipserve.clip.ubc.ca/pics/) and functions
with all major web browsers. WebPICS greatly facilitates
data processing and information access by both occasional
and expert users. In WebPICS, positional amino acid fre-
quencies ranging from P6–P69 are calculated from the list of
reconstructed cleavage sequences and presented as heatmaps
with customizable cutoffs for minimal and maximal frequen-
cy values. Heatmaps are shown for relative positional fre-
quencies of individual amino acids (in %) and positional
frequencies normalized to the natural abundance of each
amino acid. Absolute, relative, and normalized positional
occurrences are also displayed in tables. For the generation
of sequence logos and the highly useful iceLogos (Colaert
et al., 2009), cleavage sequences are accessible in a format
that allows for direct interaction with the iceLogo website
via ‘copy and paste’. Here, we report the application of
WebPICS. Because factor Xa subsite specificity is well char-
acterized, yet also somewhat controversial, we profiled these
important proteases by PICS with data analysis handled by
WebPICS as experimental proof of concept.
PICS libraries were derived from cell lysates of cultured
human embryonic kidney cells and generated by digestion
with either chymotrypsin (cleavage C-terminal to aromatic
residues as well as leucine and methionine) or Glu-C (cleav-
age C-terminal to glutamic acid and, to a lesser extent, aspar-
tic acid). Tryptic PICS libraries are not suited for factor Xa
subsite mapping because trypsin cleaves C-terminal to lysine
or arginine. Hence, tryptic PICS libraries lack internal basic
residues and are incompatible with the primary specificity of
factor Xa for P1 arginine.
For specificity screening, we used factor Xa preparations
that are supplied for the untagging of recombinant fusion
proteins (2 U/ml, Novagen). Based on vendor’s recommen-
dation, 2 U factor Xa were incubated with 200 mg PICS
library for 16 h at 378C at pH 8.0. Prime side cleavage prod-
uct isolation and LC-MS/MS analysis using a QSTAR Pulsar
tandem mass spectrometer (Applied Biosystems, Foster City,
CA, USA) coupled to an LC Packings capillary LC system
(Dionex, Sunnyvale, CA, USA) were performed exactly as
reported in our recent step-by-step protocol for PICS (Schil-
ling and Overall, 2008; Schilling et al., 2011). Details on
spectrum-to-peptide sequence assignment are provided in the
legend to Figure 1. Non-enzyme constraint spectrum-to-
sequence assignment by X! Tandem, in conjunction with
PeptideProphet (Keller et al., 2002; Craig and Beavis, 2004)
for statistical modeling of the false discovery rates identified
90 non-redundant sequences from the chymotryptic PICS
library and 34 non-redundant sequences from the Glu-C
PICS library (Supplementary Tables 1 and 2). In the chy-
motryptic assay, a small number of cleavage sites have P1
residues which correspond to a chymotryptic cleavage site.
These cases might be related to incomplete amine protection
during library preparation. Hence, prime-side cleavage prod-
ucts with chymotryptic amino-termini are omitted from the
PICS analysis as well as prime-side cleavage products with
amino termini that correspond to a protein amino terminus.
This exclusion strategy yields 86 non-redundant factor Xa
cleavage sequences for the chymotryptic PICS library.
The factor Xa specificity profiles for the chymotryptic and
Glu-C PICS libraries are shown in Figure 1 in heatmap-style
representation and as sequence logos (Colaert et al., 2009).
PICS employs proteome-derived peptide libraries with nat-
ural amino acid abundances. To correct for this bias, posi-
tional amino acid occurrences are shown in relation to their
natural abundance. In order to discern subsite specificity
from random fluctuations of positional frequencies, we focus
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Figure 1 PICS profiling of factor Xa with a chymotryptic and a Glu-C peptide library.
Chymotryptic and Glu-C PICS libraries were prepared as described previously (Schilling and Overall, 2008). 2 U factor Xa (Novagen) were
incubated with 200 mg PICS library for 16 h at 378C in 50 mM HEPES, pH 8.0, 100 mM NaCl, 5 mM CaCl2. Prime-side cleavage products
were isolated and identified by LC-MS/MS as described (Schilling and Overall, 2008). Non-enzyme constraint spectrum-to-sequence assign-
ment was applied using X! Tandem (Craig and Beavis, 2004) with a decoy search strategy in conjunction with PeptideProphet at 95%
confidence level (Keller et al., 2002). Mass tolerance was 100 ppm for parent ions and 0.1 Da for fragment ions. Static modifications were
carboxyamidomethylation of cysteine residues (q57.02 Da), dimethylation of lysine ´-amines (q28.03 Da), and thioacylation of amino-
termini (q88.00 Da). The corresponding non-prime sequences were derived bioinformatically (Schilling and Overall, 2008; Schilling et al.,
2011). Positional occurrences are shown as enrichment or depletion over natural abundance with human amino acid abundances being
derived from the International Protein Index (Kersey et al., 2004). For heatmap-style representation, only enrichments larger than two-fold
are displayed. Sequence logos were generated with iceLogo (Colaert et al., 2009). Amino acids are stated in one-letter code, cysteine (C*)
is carboxyamidomethylated and lysine (K*) is dimethylated.
on residues exceeding their natural abundance more than
two-fold. A corresponding cut-off has been applied for the
heatmap-style representation of positional frequencies but
not for the sequence logo-type depiction.
Using both libraries, PICS confirmed the canonical spec-
ificity for P1 arginine. Cleavage at P1 lysine, as described
by Gosalia et al. (Gosalia et al., 2005), was not detected as
expected since PICS employs peptide libraries with dime-
thylated lysine residues. Although dimethylation preserves
the basic character of lysine and matrix metalloproteases
show canonical P2’ specificity for dimethylated lysine
(Schilling and Overall, 2008), serine proteases with trypsin-
like specificity fail to cleave C-terminally to dimethylated
lysine. Hence PICS is not suited to probe for lysine speci-
ficity. In S2, both the chymotryptic and Glu-C PICS assays
determined the previously reported preferences for glycine
and alanine. A partial preference for phenylalanine is
observed in the Glu-C PICS assays. Here, P2 phenylalanine
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Table 1 Numerical representation of PICS specificity profiles.
(A) Factor Xa subsite mapping with a chymotryptic PICS library – positional occurrences relative to natural abundance.
P6 P5 P4 P3 P2 P1 P1’ P2’ P3’ P4’ P5’ P6’
A 0.2 0.2 0.3 0.5 2.3 0.0 2.8 2.3 1.2 1.3 1.7 1.7
C 0.0 0.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.5 0.5 0.0
D 1.0 1.2 1.2 2.0 0.3 0.3 0.0 0.3 2.0 2.0 2.2 2.0
E 0.5 0.7 0.8 0.7 1.5 0.0 0.2 0.8 1.0 1.3 0.7 1.5
F 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.6 1.0 0.3 0.3 1.0
G 0.7 1.4 0.3 0.7 5.6 0.0 1.4 1.7 2.3 2.1 1.2 0.7
H 0.0 0.0 0.5 0.5 0.9 0.0 0.5 0.0 0.0 0.0 0.5 0.5
I 0.5 0.5 1.1 2.4 0.5 0.0 0.5 0.8 1.3 1.9 1.6 1.3
K 1.4 1.4 0.4 0.6 0.4 0.0 3.1 0.0 1.2 2.5 0.4 1.0
L 0.0 0.2 0.1 0.0 0.0 0.0 0.1 1.1 0.6 0.2 0.9 0.9
M 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.6 0.0 0.5 0.5 1.0
N 0.3 0.7 0.3 2.3 1.0 0.0 0.0 0.0 0.3 0.0 1.0 2.3
P 0.4 0.7 2.7 0.7 1.1 0.0 0.4 0.5 1.2 1.4 2.2 0.7
Q 0.5 0.5 1.0 0.7 0.7 0.2 0.7 0.5 0.0 0.5 0.0 1.0
R 0.2 0.2 1.0 1.8 0.2 15.0 0.8 0.4 0.0 0.2 0.2 0.2
S 0.4 0.4 0.7 1.1 0.4 0.1 2.4 0.8 0.4 0.7 0.4 0.6
T 1.1 0.4 0.2 0.6 0.4 0.2 1.3 0.9 2.1 1.1 0.9 0.2
V 0.2 1.3 1.3 1.9 0.2 0.0 0.8 3.3 2.3 0.8 2.3 1.9
W 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0
Y 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.9 0.0 0.5 0.0 0.0
(B) Factor Xa subsite mapping with a GluC PICS library – positional occurrences relative to natural abundance.
P6 P5 P4 P3 P2 P1 P1’ P2’ P3’ P4’ P5’ P6’
A 2.9 0.4 1.7 2.9 2.1 0.0 3.4 0.8 0.4 2.1 0.8 0.8
C 1.3 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0
D 2.5 0.0 0.0 2.5 0.0 0.0 0.0 0.0 1.9 0.6 0.6 0.6
E 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.4
F 0.0 0.0 0.0 0.0 4.9 0.0 0.0 4.9 0.8 0.8 0.8 3.3
G 1.3 2.2 0.4 0.0 4.4 0.0 1.8 0.4 1.3 0.4 2.6 1.8
H 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0
I 0.7 0.7 0.7 0.7 0.0 0.0 0.7 1.4 0.7 1.4 0.7 1.4
K 0.5 2.6 0.0 2.1 0.5 0.5 2.6 0.5 0.5 1.5 2.6 0.5
L 0.3 0.6 1.2 0.9 0.6 0.3 0.3 2.4 3.0 0.3 2.1 3.9
M 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
N 0.8 0.0 0.0 1.7 1.7 0.0 0.0 0.0 0.0 0.8 2.5 1.7
P 0.0 0.4 2.3 0.4 0.9 0.0 0.0 0.0 0.9 1.8 0.9 0.4
Q 0.0 0.0 2.5 2.5 0.6 0.0 0.0 0.6 0.0 1.2 1.8 0.6
R 0.0 0.0 1.0 0.5 0.0 14.2 0.0 0.5 1.0 0.0 0.0 0.0
S 0.0 0.7 0.0 1.0 0.3 0.0 2.5 1.7 1.4 3.2 0.0 0.0
T 0.0 0.0 1.1 0.5 0.0 0.0 1.6 1.1 0.5 0.0 0.0 1.1
V 0.0 0.5 0.0 0.5 0.0 0.0 2.0 1.5 1.5 1.0 0.5 0.0
W 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0
Y 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 1.1 0.0 1.1 0.0
Positional amino acid occurrences are shown as enrichment over natural abundance with human amino acid abundances being
derived from the International Protein Index (Kersey et al., 2004).
exceeds its natural abundance 4.9-fold (Table 1). As previ-
ously discussed, the dual preference for small residues such
as glycine or alanine alongside phenylalanine is in agreement
with a number of studies on factor Xa specificity.
S3 contributes less to factor Xa specificity than S2. Both
PICS assays detect a minor preference for aspartic acid,
which exceeds its natural abundance two-fold and 2.5-fold,
respectively. Further S3 specificity determinants fail to
emerge clearly. Slight preferences for isoleucine and valine
as well as arginine are observed in the chymotryptic PICS
assay. Although these S3 preferences are corroborated by
previously discussed factor Xa profiling experiments (Fur-
long et al., 2002; Scholle et al., 2006; Hsu et al., 2008) they
are not confirmed by the Glu-C PICS assay. In S4, both PICS
assays determine a minor preference for proline. This is cor-
roborated by a specificity study employing synthetic peptide
libraries (Furlong et al., 2002). However, factor Xa PICS
profiling does not substantiate a preference for P4 isoleucine
which has been observed with the aforementioned synthetic
peptide library screen and which is frequently used to direct
factor Xa cleavage in tag removal of recombinant fusion
proteins (Nagai et al., 1985).
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Figure 2 The web-based platform for PICS data analysis.
This online resource is publicly accessible at http://clipserve.clip.ubc.ca/pics/. It primarily serves to derive non-prime cleavage sequences
for prime-site PICS cleavage sequences and generates heatmap-style, graphical representation of protease specificity (Schilling et al., 2011).
In S1’, both PICS assays determined slight selectivity for
small amino acids, such as serine and alanine. In addition,
both PICS assays indicate an S1’ preference for dimethylated
lysine. In S2’, the Glu-C PICS assay indicates a preference
for phenylalanine, leucine, and, to a lesser extent, tyrosine.
In comparison to S1’, S2’ appears to contribute more strong-
ly to factor Xa specificity. With the exception of missed
chymotryptic cleavage sites, chymotryptic PICS libraries
lack internal phenylalanine and leucine and so are not well
suited for specificity profiling for these residues. Neverthe-
less, the chymotryptic PICS assay showed valine as the most
preferred residue in S2’ and a total of 16 factor Xa cleavage
sites from the chymotryptic PICS library have an S2’ phen-
ylalanine, leucine or tyrosine, possibly stemming from PICS
peptides with missed chymotryptic cleavages that could then
be recognized by factor Xa. In conclusion, both the Glu-C
and chymotryptic PICS assays indicate an S2’ preference for
aromatic and aliphatic residues. For S3’, both PICS assays
detect a minor preference for aspartic acid. Overall however,
S3’ appears to have a very limited contribution to factor Xa
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selectivity. Altogether, subsite mapping of factor Xa substan-
tiates previous findings about its extended active site speci-
ficity and refines our knowledge about prime-site specificity
determinants.
The present PICS profiling of factor Xa represents the first
reported application of WebPICS, our new web-based plat-
form for automated PICS data analysis, http://clipserve.
clip.ubc.ca/pics/ (Figure 2). At the same site, instructions for
use are also found online at http://clipserve.clip.ubc.ca/pics/
manual.pdf. Notably, the new WebPICS platform also pro-
cesses data from in vivo cleavage experiments that employ
native protein substrates (Kleifeld et al., 2010) to enable
comparison of specificity determinants for peptidic and
native protein substrates. In addition, prime-side cleavage
sequences from any N-terminal proteomics experiment can
be used, not only PICS (Schilling and Overall, 2008), but
also TAILS (Kleifeld et al., 2010), COFRADIC (Van Damme
et al., 2005), and N-terminal biotinylation schemes (Timmer
et al., 2007; Mahrus et al., 2008). Such data can be easily
entered via ‘copy and paste’ and rendered non-redundant.
Input sequences can originate from any MS/MS analysis
software. For PeptideProphet, non-sequence information
such as preceding residues or modified masses are automat-
ically removed. Prime-side sequences are then extended
N-terminally until the first potential cleavage site of the
digestion protease used in peptide library generation (Schil-
ling and Overall, 2008). Trypsin, chymotrypsin, and Glu-C
are supported as digestion proteases and human, mouse, and
E. coli are supported as proteome sources. Arabidopsis will
be added soon. In summary, the web-based PICS platform
makes PICS specificity profiling widely accessible and
removes the need for expert knowledge in data processing.
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